Tuesday, October 27, 2020
NIH Halts Study Exploring Treating Covid-19 With Lilly Antibody, Remdesivir - WSJ
NIH Halts Study Exploring Treating Covid-19 With Lilly Antibody, Remdesivir - WSJ: Federal health researchers have halted testing a combination of Eli Lilly’s Covid-19 antibody drug and remdesivir in hospitalized Covid-19 patients, after an independent committee found a lack of a benefit.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment